19-51716824-C-T

Variant names:

• chr19-51716824-C-T
• rs11084110
• NM_001297436.2:c.925+144G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001297436.2(HAS1):​c.925+144G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.713 in 675,066 control chromosomes in the GnomAD database, including 174,180 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.67 (34916 hom., cov: 29)
  • Exomes 𝑓: 0.73 (139264 hom.)
• Consequence: HAS1 NM_001297436.2 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.0530
• Publications: 8 publications found

Genes affected

HAS1 (HGNC:4818): (hyaluronan synthase 1) Hyaluronan or hyaluronic acid (HA) is a high molecular weight unbranched polysaccharide synthesized by a wide variety of organisms from bacteria to mammals, and is a constituent of the extracellular matrix. It consists of alternating glucuronic acid and N-acetylglucosamine residues that are linked by beta-1-3 and beta-1-4 glycosidic bonds. HA is synthesized by membrane-bound synthase at the inner surface of the plasma membrane, and the chains are extruded through pore-like structures into the extracellular space. It serves a variety of functions, including space filling, lubrication of joints, and provision of a matrix through which cells can migrate. HA is actively produced during wound healing and tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts. Changes in the serum concentration of HA are associated with inflammatory and degenerative arthropathies such as rheumatoid arthritis. In addition, the interaction of HA with the leukocyte receptor CD44 is important in tissue-specific homing by leukocytes, and overexpression of HA receptors has been correlated with tumor metastasis. HAS1 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to the hasA gene product of Streptococcus pyogenes, a glycosaminoglycan synthetase (DG42) from Xenopus laevis, and a recently described murine hyaluronan synthase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.87).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.852 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001297436.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	HAS1	NM_001297436.2	MANE Select	c.925+144G>A		intron	N/A	NP_001284365.1	G3V1S7
	HAS1	NM_001523.4		c.928+144G>A		intron	N/A	NP_001514.2	Q92839

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	HAS1	ENST00000540069.7	TSL:1 MANE Select	c.925+144G>A		intron	N/A	ENSP00000445021.2	G3V1S7
	HAS1	ENST00000601714.5	TSL:1	c.949+144G>A		intron	N/A	ENSP00000472821.1	M0R2V0
	HAS1	ENST00000222115.5	TSL:1	c.928+144G>A		intron	N/A	ENSP00000222115.1	Q92839

Frequencies

GnomAD3 genomes AF: 0.670 AC: 101598 AN: 151682 Hom.: 34885 Cov.: 29

Gnomad AFR AF: 0.521

Gnomad AMI AF: 0.571

Gnomad AMR AF: 0.749

Gnomad ASJ AF: 0.693

Gnomad EAS AF: 0.873

Gnomad SAS AF: 0.755

Gnomad FIN AF: 0.797

Gnomad MID AF: 0.680

Gnomad NFE AF: 0.702

Gnomad OTH AF: 0.651

GnomAD4 exome AF: 0.725 AC: 379525 AN: 523266 Hom.: 139264 AF XY: 0.726 AC XY: 201438 AN XY: 277634

African (AFR) AF: 0.506 AC: 7588 AN: 15000

American (AMR) AF: 0.813 AC: 24815 AN: 30522

Ashkenazi Jewish (ASJ) AF: 0.692 AC: 11114 AN: 16050

East Asian (EAS) AF: 0.902 AC: 29297 AN: 32478

South Asian (SAS) AF: 0.760 AC: 41585 AN: 54696

European-Finnish (FIN) AF: 0.785 AC: 26716 AN: 34020

Middle Eastern (MID) AF: 0.610 AC: 1411 AN: 2312

European-Non Finnish (NFE) AF: 0.700 AC: 216484 AN: 309110

Other (OTH) AF: 0.706 AC: 20515 AN: 29078

GnomAD4 genome AF: 0.670 AC: 101683 AN: 151800 Hom.: 34916 Cov.: 29 AF XY: 0.678 AC XY: 50284 AN XY: 74188

African (AFR) AF: 0.521 AC: 21548 AN: 41352

American (AMR) AF: 0.750 AC: 11428 AN: 15246

Ashkenazi Jewish (ASJ) AF: 0.693 AC: 2405 AN: 3468

East Asian (EAS) AF: 0.873 AC: 4499 AN: 5154

South Asian (SAS) AF: 0.755 AC: 3626 AN: 4804

European-Finnish (FIN) AF: 0.797 AC: 8395 AN: 10532

Middle Eastern (MID) AF: 0.694 AC: 204 AN: 294

European-Non Finnish (NFE) AF: 0.702 AC: 47683 AN: 67938

Other (OTH) AF: 0.654 AC: 1375 AN: 2102

Alfa AF: 0.612 Hom.: 1793

Bravo AF: 0.674

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.87
CADD	Benign	0.65
DANN	Benign	0.68
PhyloP100		-0.053
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs11084110; hg19: chr19-52220077;